Skip to main content

Clinical Watch: May 2018

Download PDF

In this issue of Clinical Watch, we discuss recently approved HIV-1 therapies. We suggest criteria for a new drug treatment for glaucoma and review a study evaluating the cardiovascular safety of three newer oral antihyperglycemic classes. Lastly, we review claims data to evaluate utilization trends with gabapentin and with gabapentin and opioids.

For more information about our solutions, please visit